Related Experiment Video
Updated: Jun 3, 2025
Manufacture and Drug Delivery Applications of Silk Nanoparticles
Published on: October 8, 2016
Global research trends and emerging hotspots in nano-drug delivery systems for lung cancer: a comprehensive
Cao Yu1,2, Chong-Qi Fan1, Yao-Xuan Chen1
1Department of Cardiothoracic Surgery, The First Affiliated Hospital of Chongqing Medical University, No.1, Youyi Road, Yuzhong District, Chongqing, 400010, China.
Purpose:
Nano-drug delivery systems (NDDS) have become a promising alternative and adjunctive strategy for lung cancer (LC) treatment. However, comprehensive bibliometric analyses examining global research efforts on NDDS in LC are scarce. This study aims to fill this gap by identifying key research trends, emerging hotspots, and collaboration networks within the field of NDDS and LC.
Methods:
A total of 2452 publications, spanning from 1998 to 2024, were extracted from the Web of Science Core Collection. The data were analyzed using tools such as VOSviewer, CiteSpace, and the R package 'bibliometrix'.
Results:
The analysis covered contributions from 12,539 researchers affiliated with 2689 institutions across 55 countries, with their work published in 551 different journals. Research output has increased steadily, with China and the United States leading in both publication volume and impact. Major contributors include the Chinese Academy of Sciences and Shanghai Jiao Tong University. The International Journal of Nanomedicine published the most articles, while Journal of Controlled Release ranked highest in co-citations. Kamal Dua authored the most papers, and Maeda, H. was the most frequently co-cited author. Key research areas encompass "active targeting", "drug delivery optimization", "overcoming drug resistance", "nanocarriers", and "pulmonary drug delivery". Emerging hotspots include "epithelial mesenchymal transition", "mucus penetration", "lipid nanoparticles", "hydrogels", and "immune checkpoint inhibitors".
Conclusion:
This bibliometric analysis, the first comprehensive study on NDDS in LC, identifies China and the United States as leading contributors in publication volume and impact. Key research areas include "active targeting" and "drug delivery optimization", with emerging hotspots such as "lipid nanoparticles" and "immune checkpoint inhibitors". These findings provide essential insights to guide future research and optimize treatment strategies.
Insights
This bibliometric analysis reveals China and the US lead global research in nano-drug delivery systems (NDDS) for lung cancer (LC). Key areas include active targeting and drug delivery optimization, with emerging hotspots in lipid nanoparticles and immune checkpoint inhibitors.
Area of Science:
- * Nanomedicine and Oncology
- * Bibliometrics and Research Trends
- * Lung Cancer Therapeutics
Background:
- * Nano-drug delivery systems (NDDS) offer promising strategies for lung cancer (LC) treatment.
- * Comprehensive bibliometric analyses of global research on NDDS in LC are limited.
- * This study addresses the need for a detailed overview of the field's landscape.
Purpose of the Study:
- * To conduct a comprehensive bibliometric analysis of global research on NDDS for LC.
- * To identify key research trends, emerging hotspots, and collaboration networks.
- * To provide insights for future research directions and optimize LC treatment strategies.
Main Methods:
- * Analysis of 2452 publications from 1998 to 2024 from the Web of Science Core Collection.
- * Utilization of bibliometric tools including VOSviewer, CiteSpace, and the R package 'bibliometrix'.
- * Examination of publication volume, impact, institutional contributions, and author networks.
Main Results:
- * China and the United States are the leading countries in publication volume and impact.
- * Key research areas include active targeting, drug delivery optimization, overcoming drug resistance, nanocarriers, and pulmonary drug delivery.
- * Emerging hotspots include epithelial mesenchymal transition, mucus penetration, lipid nanoparticles, hydrogels, and immune checkpoint inhibitors.
Conclusions:
- * This bibliometric analysis is the first comprehensive study on NDDS in LC.
- * China and the US lead in research output and impact in this field.
- * Findings highlight critical research areas and emerging hotspots to guide future therapeutic development for lung cancer.
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
01:22Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...